NCT00169221View on ClinicalTrials.gov

Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas

PHASE2TerminatedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2011

Conditions
Head and Neck Cancer
Interventions
DRUG

Iressa (Gefitinib)

postoperative chemoradiotherapy with cisplatin + gefitinib

RADIATION

chemoradiotherapy with cisplatin

postoperative chemoradiotherapy with cisplatin

Trial Locations (1)

06189

Centre Antoine Lacassagne, Nice

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Groupe Oncologie Radiotherapie Tete et Cou

OTHER

NCT00169221 - Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas | Biotech Hunter | Biotech Hunter